Lifepoint Health, Eon Release Data Showing Why Identification and Follow-Up of Incidental Findings are Integral to Improving Breast Cancer Diagnosis and OutcomesMorningStar·Mar 18 at 07:51 AMEONR++12.50%EONR-0.72%
